230 related articles for article (PubMed ID: 26444780)
1. Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
Triplett JC; Swomley AM; Cai J; Klein JB; Butterfield DA
J Alzheimers Dis; 2016; 49(1):45-62. PubMed ID: 26444780
[TBL] [Abstract][Full Text] [Related]
2. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
[TBL] [Abstract][Full Text] [Related]
3. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
4. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.
Aluise CD; Robinson RA; Beckett TL; Murphy MP; Cai J; Pierce WM; Markesbery WR; Butterfield DA
Neurobiol Dis; 2010 Aug; 39(2):221-8. PubMed ID: 20399861
[TBL] [Abstract][Full Text] [Related]
6. Pathology of clinical and preclinical Alzheimer's disease.
Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR
Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule.
Reed TT; Pierce WM; Turner DM; Markesbery WR; Allan Butterfield D
J Cell Mol Med; 2009 Aug; 13(8B):2019-2029. PubMed ID: 18752637
[TBL] [Abstract][Full Text] [Related]
8. Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.
Gefen T; Gasho K; Rademaker A; Lalehzari M; Weintraub S; Rogalski E; Wieneke C; Bigio E; Geula C; Mesulam MM
Brain; 2012 May; 135(Pt 5):1554-65. PubMed ID: 22522938
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
Nelson PT; Abner EL; Scheff SW; Schmitt FA; Kryscio RJ; Jicha GA; Smith CD; Patel E; Markesbery WR
Neurosci Lett; 2009 Feb; 450(3):336-9. PubMed ID: 19010392
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.
Sultana R; Banks WA; Butterfield DA
J Neurosci Res; 2010 Feb; 88(3):469-77. PubMed ID: 19774677
[TBL] [Abstract][Full Text] [Related]
14. Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.
Sabbagh MN; Cooper K; DeLange J; Stoehr JD; Thind K; Lahti T; Reisberg B; Sue L; Vedders L; Fleming SR; Beach TG
Curr Alzheimer Res; 2010 Jun; 7(4):280-6. PubMed ID: 19715548
[TBL] [Abstract][Full Text] [Related]
15. The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.
Aghakhanyan G; Vergallo A; Gennaro M; Mazzarri S; Guidoccio F; Radicchi C; Ceravolo R; Tognoni G; Bonuccelli U; Volterrani D
Neurodegener Dis; 2018; 18(5-6):302-309. PubMed ID: 30814473
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.
Scheff SW; Ansari MA; Mufson EJ
Neurobiol Aging; 2016 Jun; 42():1-12. PubMed ID: 27143416
[TBL] [Abstract][Full Text] [Related]
17. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
[TBL] [Abstract][Full Text] [Related]
18. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
[TBL] [Abstract][Full Text] [Related]
19. The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
Di Domenico F; Owen JB; Sultana R; Sowell RA; Perluigi M; Cini C; Cai J; Pierce WM; Butterfield DA
J Neurosci Res; 2010 Dec; 88(16):3566-77. PubMed ID: 20936705
[TBL] [Abstract][Full Text] [Related]
20. Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.
Perez SE; He B; Nadeem M; Wuu J; Scheff SW; Abrahamson EE; Ikonomovic MD; Mufson EJ
Biol Psychiatry; 2015 Apr; 77(8):693-703. PubMed ID: 24529280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]